Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy

Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey

(2013) A. Hernandez-Madrid et al.   EUROPACE

Thromboembolic Complications After Cardioversion of Acute Atrial Fibrillation

(2013) K. E. Juhani Airaksinen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation

(2013) Greg Flaker et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation

(2011) Rangadham Nagarakanti et al.   CIRCULATION

Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation

(2010) Morten L. Hansen et al.   ARCHIVES OF INTERNAL MEDICINE

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPACE

Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort study

(2010) Charlotte Andersson et al.   EUROPEAN JOURNAL OF HEART FAILURE